Clinical Trial Update: Cognitive Activation Therapy for MCI: A Randomized Control Study [Phase 1]

View source ↗

Summary

This clinical trial update outlines a Phase 1 randomized controlled study of Cognitive Activation Therapy for Mild Cognitive Impairment, sponsored by Rotman Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Rotman Research Institute at Baycrest | Conditions: Mild Cognitive Impairment | Phase 1 | Status: UNKNOWN